NOVEMBER 2024LIFE SCIENCES REVIEW 19Bridging Gaps in Patient Care with Innovative Therapeutic SolutionsAt the forefront of our process is the understanding that the starting point of a solution is a doctor's recommendation. We possess the ability to listen to and deeply understand the needs of that customer segmentwith global regulatory standards. Helping to establish its credibility in the market, NTC has a strong history of publishing research. Many contributors to these studies belong to various European countries, showcasing the collective efforts involved in their research. With strong development skills and extensive regulatory knowledge, NTC is well-equipped to design and validate its innovative ideas. It associates with reputable contract development and manufacturing organizations with the right technologies to bring their concepts to life. The result is a pipeline of products that address pressing medical needs while adhering to the highest standards of efficacy and safety.The products are commercialized globally through a B2B model that includes partnerships with over 200 licensees and distributors in more than 100 countries. This comprehensive approach--from need identification to product development, clinical validation, and global distribution--ensures that it continuously delivers innovative, high-quality solutions that align with the evolving needs of healthcare providers and patients worldwide.Improving Patient Care Through Innovation and ESG LeadershipThroughout its path to commercialization, NTC relies on a team of professionals with decades of experience, many of whom were recruited from large multinational companies. These experts collaborate with the leadership team to transform insights and ideas gathered from the medical community into effective products.A notable achievement of the NTC team is the development of a combination drug designed for patients undergoing post-cataract surgery. The innovative solution in eye drops effectively reduces the reliance on antibiotics while providing adequate prevention against potentially severe side effects associated with the surgery. Backed by extensive clinical trials and large data sets, the product has gained international recognition and is currently marketed in over 60 countries. NTC aims to expand the product's reach to approximately 90 countries in the next 24 months.NTC strives to deliver its solutions while staying deeply committed to environmental, social, and governance (ESG) principles. It prioritizes the development of products that minimize carbon footprints and promote sustainability. ESG considerations are embedded from the earliest stages of product development, ensuring responsible practices throughout the manufacturing process. This commitment to sustainability is a guiding principle within the organization and is an important aspect to highlight in discussions about its mission and values.As NTC continues to innovate and expand its product offerings, it remains steadfast in its dedication to enhancing patient care and making a positive impact on global healthcare--one solution at a time.
< Page 9 | Page 11 >